Louis Stavart

🤸🏾‍♂️ Excited to share our latest article in @FrontMedicine. This is the first report on the use of a Bruton tyrosine kinase inhibitor 💊 for chronic lymphocytic leukemia infiltrating a kidney transplant. Also check out our extensive review ! 🔎 frontiersin.org/journals/medic…

(3/3) My submission represents a celebration ball where attendees are immune cells or pathogens, surrounded by discoveries in immunology over the last 30 years. The open sky shows the boundless possibilities of future advances. Can you identify all the cells and breakthroughs?

(2/3) Our research focuses on the immune system's role in the transition to fibrosis after renal ischemia-reperfusion injury and kidney transplantation. We specifically explore the influence of sex in immune responses. The goal is to improve kidney recipients' care and outcomes.

(1/3) Thrilled to have participated in @ImmunityCP's 30th anniversary cover contest. Many thanks to @KavithaSci for encouraging us to showcase our work, and congrats to @elnlnx! So grateful to be Prof Dela Golshayan and Dr @AlbanLongchamp's MD-PhD student @CHUVLausanne @unil!